BRCA1 and triple-negative breast carcinoma: The prevalence of a germline BRCA1/2 mutation was reported to be 11.2% in unselected TNBC patients, which is significantly higher than its prevalence in non-triple-negative breast cancers, and the BRCA1 mutation was more common than BRCA245,46.